Multinu Francesco, Harrington Sean C, Chen Jun, Jeraldo Patricio R, Johnson Stephen, Chia Nicholas, Walther-Antonio Marina R
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA.
Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
mSphere. 2018 Mar 14;3(2). doi: 10.1128/mSphere.00560-17. eCollection 2018 Mar-Apr.
Variability in representation of microbial communities can be caused by differences in microbial composition or artifacts introduced at sample collection or processing. Alterations in community representation introduced by variations in starting DNA concentrations have not been systematically investigated in stool samples. The goal of this study was to evaluate the effect of the genomic DNA (gDNA) concentration in the resulting 16S rRNA gene library composition and compare its effect to other sample processing variables in homogenized human fecal material. Compared to a gDNA input of 1 ng/μl, inputs of ≤1.6 × 10 ng/μl resulted in a marked decrease in the concentration of the 16S rRNA gene amplicon ( < 0.001). Low gDNA concentrations (≤1.6 × 10 ng/μl) were also associated with a decrease ( < 0.001) in the number of operational taxonomic units and significant divergence in β-diversity profiles (unweighted UniFrac distance, < 0.001), as characterized by an overestimation of and underestimation of . Even a gDNA concentration of 4 × 10 ng/μl showed a significant impact on the β-diversity profile (unweighted UniFrac distance, = 0.03). Overall, the gDNA concentration explained 22.4% to 38.1% of the microbiota variation based on various β-diversity measures ( < 0.001). By comparison, the DNA extraction methods and PCR volumes tested did not significantly affect the microbial composition profile, and the PCR cycling method explained less than 3.7% of the microbiota variation (weighted UniFrac distance, = 0.03). The 16S rRNA gene yield and the microbial community representation of human homogenized stool samples are significantly altered by gDNA template concentrations of ≤1.6 × 10 ng/μl. In addition, data from studies with a gDNA input of ≤4 × 10 ng/μl should be interpreted with caution. The genomic DNA input for stool samples utilized for microbiome composition has not been determined. In this study, we determined the reliable threshold level under which conclusions drawn from the data may be compromised. We also determined the type of microbial bias introduced by less-than-ideal genomic input.
微生物群落表征的变异性可能由微生物组成的差异或样本采集或处理过程中引入的人为因素引起。粪便样本中起始DNA浓度变化所导致的群落表征改变尚未得到系统研究。本研究的目的是评估基因组DNA(gDNA)浓度对所得16S rRNA基因文库组成的影响,并将其与均质化人类粪便样本中的其他样本处理变量的影响进行比较。与1 ng/μl的gDNA输入量相比,≤1.6×10 ng/μl的输入量导致16S rRNA基因扩增子浓度显著降低(<0.001)。低gDNA浓度(≤1.6×10 ng/μl)还与操作分类单元数量的减少(<0.001)以及β-多样性图谱的显著差异(非加权UniFrac距离,<0.001)相关,其特征为高估和低估。即使gDNA浓度为4×10 ng/μl也对β-多样性图谱有显著影响(非加权UniFrac距离,=0.03)。总体而言,基于各种β-多样性测量,gDNA浓度解释了22.4%至38.1%的微生物群变异(<0.001)。相比之下,所测试的DNA提取方法和PCR体积对微生物组成图谱没有显著影响,且PCR循环方法解释的微生物群变异小于3.7%(加权UniFrac距离,=0.03)。≤1.6×10 ng/μl的gDNA模板浓度会显著改变人类均质化粪便样本的16S rRNA基因产量和微生物群落表征。此外,gDNA输入量≤4×10 ng/μl的研究数据应谨慎解读。用于微生物组组成的粪便样本的基因组DNA输入量尚未确定。在本研究中,我们确定了可靠的阈值水平,低于该水平可能会影响从数据得出的结论。我们还确定了不理想的基因组输入所引入的微生物偏差类型。